Ilse Roodink
Chief Tech/Sci/R&D Officer at IMMUNOPRECISE ANTIBODIES LTD.
Net worth: 14 504 $ as of 2024-03-30
Profile
Ilse Roodink is currently the Chief Scientific Officer at ImmunoPrecise Antibodies Ltd.
She previously worked as the Scientific Director at Immunoprecise Antibodies (Europe) BV.
Dr. Roodink received her undergraduate, graduate, and doctorate degrees from Radboud University Nijmegen.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-17 | 9,542 ( 0.04% ) | 14 504 $ | 2024-03-30 |
Ilse Roodink active positions
Companies | Position | Start |
---|---|---|
IMMUNOPRECISE ANTIBODIES LTD. | Chief Tech/Sci/R&D Officer | 2021-06-30 |
Former positions of Ilse Roodink
Companies | Position | End |
---|---|---|
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Training of Ilse Roodink
Radboud University Nijmegen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IMMUNOPRECISE ANTIBODIES LTD. | Health Technology |
Private companies | 1 |
---|---|
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Ilse Roodink